These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15537710)

  • 1. Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i.
    López JR; Linares N; Pessah IN; Allen PD
    Am J Physiol Cell Physiol; 2005 Mar; 288(3):C606-12. PubMed ID: 15537710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
    López JR; Contreras J; Linares N; Allen PD
    Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
    Weigl LG; Ludwig-Papst C; Kress HG
    Anesth Analg; 2004 Jul; 99(1):103-107. PubMed ID: 15281512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
    Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
    Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Halsal JP; Steele DS
    Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle.
    Herrmann-Frank A; Richter M; Lehmann-Horn F
    Biochem Pharmacol; 1996 Jul; 52(1):149-55. PubMed ID: 8678899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+ influx via the Na+/Ca2+ exchanger is enhanced in malignant hyperthermia skeletal muscle.
    Altamirano F; Eltit JM; Robin G; Linares N; Ding X; Pessah IN; Allen PD; López JR
    J Biol Chem; 2014 Jul; 289(27):19180-90. PubMed ID: 24847052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
    Sei Y; Brandom BW; Bina S; Hosoi E; Gallagher KL; Wyre HW; Pudimat PA; Holman SJ; Venzon DJ; Daly JW; Muldoon S
    Anesthesiology; 2002 Nov; 97(5):1052-8. PubMed ID: 12411786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.
    Wehner M; Rueffert H; Koenig F; Neuhaus J; Olthoff D
    Clin Genet; 2002 Aug; 62(2):135-46. PubMed ID: 12220451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
    Gilly H; Musat I; Fricker R; Bittner RE; Steinbereithner K; Kress HG
    Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
    Du GG; Oyamada H; Khanna VK; MacLennan DH
    Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swine.
    Wappler F; Scholz J; Fiege M; Kolodzie K; Kudlik C; Weisshorn R; Schulte am Esch J
    Anesthesiology; 1999 Jun; 90(6):1733-40. PubMed ID: 10360873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
    Lopez JR; Kaura V; Diggle CP; Hopkins PM; Allen PD
    Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ryanodine receptor mutation that may cause malignant hyperthermia.
    Kaufmann A; Kraft B; Michalek-Sauberer A; Weigl LG
    Anesthesiology; 2008 Sep; 109(3):457-64. PubMed ID: 18719443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Mg(2+) and SR luminal Ca(2+) on caffeine-induced Ca(2+) release in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Steele DS
    J Physiol; 2002 Oct; 544(Pt 1):85-95. PubMed ID: 12356882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia.
    Freymond D; Dériaz O; Frascarolo P; Reiz S; Jéquier E; Urwyler A
    Anesthesiology; 2000 Jul; 93(1):39-47. PubMed ID: 10861144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
    Wehner M; Rueffert H; Koenig F; Olthoff D
    Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.